{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T18:45:19Z","timestamp":1782413119274,"version":"3.54.5"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Residential medication management reviews (RMMRs) are a government-funded program in Australia, designed to optimise medication use and enhance safety in aged care residents through reviews conducted by credentialed pharmacists. However, variability in general practitioners\u2019 (GPs) implementation of pharmacists\u2019 recommendations may limit their effectiveness. This study investigated the recommendations made by pharmacists during RMMRs, and the aspects of the recommendations that were associated with their subsequent implementation by GPs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study analysed RMMRs from 54 aged care facilities across Tasmania, Australia between January 2020 and December 2023. Residents with at least two RMMRs spaced approximately 12 months apart were included, with data extracted from the earliest eligible RMMR as the index. Data sources included medication profiles, residents\u2019 clinical histories, RMMR reports, GP feedback forms, and follow-up RMMRs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 1646 index RMMRs analysed, 3774 recommendations were made (median: 2 per RMMR), with 50% (n = 1872) fully implemented by the next RMMR 12 months later. Most recommendations (91%, n = 3380) involved a change in therapy, primarily medicine cessation (49%, n = 1810) or dose reduction (21%, n = 799), with implementation rates of 51% and 49%, respectively. Common deprescribing targets included colecalciferol (n = 318, 37% implemented), proton pump inhibitors (n = 123, 43% implemented), statins (n = 145, 48% implemented), and low-dose aspirin (n = 107, 63% implemented). One in six recommendations involved a potentially inappropriate medicine (PIM) according to an Australian resource, such as antipsychotics, benzodiazepines, and opioids. Implementation rates were comparable between deprescribing of PIMs and non-PIMs (51% vs. 50%, p &amp;gt; 0.9). Monitoring-related recommendations were significantly more likely to be implemented than those involving a change in therapy (73% vs. 48%, p &amp;lt; 0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Half of all recommendations were implemented by GPs within 12 months, with most targeting the deprescribing of preventive or high-risk medicines. Future research should identify which recommendations GPs prioritise and the factors influencing their implementation of pharmacists\u2019 medication review recommendations, in order to enhance the effectiveness of RMMRs in aged care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2025.1690600","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:41:25Z","timestamp":1761720085000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Implementation of pharmacist recommendations following medication reviews in aged care"],"prefix":"10.3389","volume":"16","author":[{"given":"Noah C.","family":"Ramsey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Mirkazemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S.","family":"Salahudeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"B1","article-title":"Quality use of medicines and medicines safety (10th national health priority)","volume-title":"Discussion paper for public consultation - phase 1: aged care","year":"2020"},{"key":"B2","unstructured":"Medication management programs: pharmacy programs administrator\n          \n          \n          2025"},{"key":"B3","unstructured":"Australian government department of health and aged care\n          \n          \n          2025"},{"key":"B4","unstructured":"Providers, services and places in aged care canberra: GEN Aged Care Data; 2025"},{"key":"B5","unstructured":"People using aged care Canberra: GEN Aged Care Data"},{"key":"B6","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(18)30265-1","article-title":"Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis","volume":"6","author":"Bolland","year":"2018","journal-title":"Lancet Diabetes and Endocrinol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"18964","DOI":"10.1038\/s41598-020-75888-8","article-title":"Polypharmacy, hospitalization, and mortality risk: a nationwide cohort study","volume":"10","author":"Chang","year":"2020","journal-title":"Sci. Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. chronic Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/ajag.12676","article-title":"Process, impact and outcomes of medication review in Australian residential aged care facilities: a systematic review","volume":"38","author":"Chen","year":"2019","journal-title":"Australas. J. Ageing"},{"key":"B10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jamda.2019.10.022","article-title":"Adverse outcomes of polypharmacy in older people: systematic review of reviews","volume":"21","author":"Davies","year":"2020","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"B11","volume-title":"Denosumab: product information","year":"2025"},{"key":"B12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3390\/healthcare11030422","article-title":"Prevalence of potentially inappropriate prescriptions according to the new STOPP\/START criteria in nursing homes: a systematic review","volume":"11","author":"D\u00edaz Planelles","year":"2023","journal-title":"Healthcare"},{"key":"B13","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/jcpt.12688","article-title":"How confident are physicians in deprescribing for the elderly and what barriers prevent deprescribing?","volume":"43","author":"Djatche","year":"2018","journal-title":"J. Clin. Pharm. Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/S0140-6736(17)31047-4","article-title":"Medication without harm: who's third global patient safety challenge","volume":"389","author":"Donaldson","year":"2017","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.3390\/jcm11175189","article-title":"Quality use of medicines indicators and associated factors in residential aged care facilities: Baseline findings from the pharmacists in RACF Study in Australia","volume":"11","author":"Haider","year":"2022","journal-title":"J. Clin. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/1715163514536678","article-title":"Paying pharmacists for patient care:a systematic review of remunerated pharmacy clinical care services","volume":"147","author":"Houle","year":"2014","journal-title":"Can. Pharm. J.\/Revue des Pharm. Du Can."},{"key":"B17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12875-016-0577-x","article-title":"Effectiveness of medication review: a systematic review and meta-analysis of randomized controlled trials","volume":"18","author":"Huiskes","year":"2017","journal-title":"BMC Fam. Pract."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e335","DOI":"10.1016\/S2468-2667(22)00013-5","article-title":"Global, regional, and national trends in opioid analgesic consumption from 2015 to 2019: a longitudinal study","volume":"7","author":"Ju","year":"2022","journal-title":"Lancet Public Health"},{"key":"B19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/intqhc\/mzs015","article-title":"Prevalence of preventable medication-related hospitalizations in Australia: an opportunity to reduce harm","volume":"24","author":"Kalisch","year":"2012","journal-title":"Int. J. Qual. Health Care"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1111\/ajag.12975","article-title":"Medication-related hospital admissions in aged care residents","volume":"40","author":"Kalisch","year":"2021","journal-title":"Australas. J. Ageing"},{"key":"B21","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.sapharm.2015.12.004","article-title":"Are residents of aged care facilities willing to have their medications deprescribed?","volume":"12","author":"Kalogianis","year":"2016","journal-title":"Res. Soc. Adm. Pharm."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s40266-023-01071-z","article-title":"Patient perceptions of opioids and benzodiazepines and attitudes toward deprescribing","volume":"40","author":"Kelley","year":"2023","journal-title":"Drugs and Aging"},{"key":"B23","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1080\/03007995.2018.1424624","article-title":"Impact of medication reviews on inappropriate prescribing in aged care","volume":"34","author":"Koria","year":"2018","journal-title":"Curr. Med. Res. Opin."},{"key":"B24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s40266-012-0048-6","article-title":"The relationship between the extent of collaboration of general practitioners and pharmacists and the implementation of recommendations arising from medication review: a systematic review","volume":"30","author":"Kwint","year":"2013","journal-title":"Drugs and Aging"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e478","DOI":"10.1111\/ajag.12827","article-title":"Pharmacist-led medication reviews in aged care residents with dementia: a systematic review","volume":"39","author":"McDerby","year":"2020","journal-title":"Australas. J. Ageing"},{"key":"B26","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1185\/03007995.2015.1105794","article-title":"Impact of residential medication management reviews on anticholinergic burden in aged care residents","volume":"32","author":"McLarin","year":"2016","journal-title":"Curr. Med. Res. Opin."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/nejmoa1805819","article-title":"Effect of aspirin on cardiovascular events and bleeding in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"134","DOI":"10.5694\/mja2.52713","article-title":"Prescription opioid supply-restricting policies and hospital use by people prescribed opioid medications, Victoria, 2018\u201322: a controlled interrupted time series analysis","volume":"223","author":"Nielsen","year":"2025","journal-title":"Med. J. Aust."},{"key":"B29","doi-asserted-by":"publisher","first-page":"677","DOI":"10.2165\/11316440-000000000-00000","article-title":"Impact of residential medication management reviews on drug burden index in aged-care homes: a retrospective analysis","volume":"26","author":"Nishtala","year":"2009","journal-title":"Drugs and Aging"},{"key":"B30","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s40266-022-00967-6","article-title":"Primary-Care prescribers\u2019 perspectives on deprescribing opioids and benzodiazepines in older adults","volume":"39","author":"Niznik","year":"2022","journal-title":"Drugs and Aging"},{"key":"B31","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s41999-023-00777-y","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 3","volume":"14","author":"O'Mahony","year":"2023","journal-title":"Eur. Geriatr. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/bcp.12975","article-title":"The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis","volume":"82","author":"Page","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"104849","DOI":"10.1016\/j.archger.2022.104849","article-title":"Polypharmacy and medicine regimens in older adults in residential aged care","volume":"105","author":"Page","year":"2023","journal-title":"Archives Gerontology Geriatrics"},{"key":"B34","unstructured":"Royal Commission into aged care quality and safety final report: care, dignity and respect\n          \n          \n            \n              Pagone\n              G.\n            \n            \n              Briggs\n              L.\n            \n          \n          \n          2021"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"American Geriatrics Society 2023 updated AGS Beers criteria\u00ae for potentially inappropriate medication use in older adults","volume":"71","author":"Panel","year":"2023","journal-title":"J. Am. Geriatr. Soc."},{"key":"B36","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s40264-017-0528-z","article-title":"Adverse drug reaction-related hospitalizations in elderly Australians: a prospective cross-sectional Study in two tasmanian hospitals","volume":"40","author":"Parameswaran","year":"2017","journal-title":"Drug Saf."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med. Care"},{"key":"B38","doi-asserted-by":"publisher","first-page":"105462","DOI":"10.1016\/j.jamda.2024.105462","article-title":"Factors influencing medical Prescribers' Acceptance of Pharmacists\u2019 recommendations in non-hospitalized older adults: a systematic review and meta-analysis","volume":"26","author":"Ramsey","year":"2025","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"B39","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/ajag.13316","article-title":"Comparison of polypharmacy and potentially inappropriate medication use in older adults with and without dementia receiving residential medication management reviews","volume":"43","author":"Sawan","year":"2024","journal-title":"Australas. J. Ageing"},{"key":"B40","doi-asserted-by":"publisher","first-page":"afac149","DOI":"10.1093\/ageing\/afac149","article-title":"Provision of a comprehensive medicines review is associated with lower mortality risk for residents of aged care facilities: a retrospective cohort study","volume":"51","author":"Sluggett","year":"","journal-title":"Age Ageing"},{"key":"B41","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1186\/s12877-022-03187-0","article-title":"Medicines use before and after comprehensive medicines review among residents of long-term care facilities: a retrospective cohort study","volume":"22","author":"Sluggett","year":"","journal-title":"BMC Geriatr."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e009781","DOI":"10.1136\/bmjopen-2015-009781","article-title":"What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals","volume":"6","author":"Turner","year":"2016","journal-title":"BMJ Open"},{"key":"B43","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1111\/imj.16322","article-title":"Development of a list of Australian potentially inappropriate medicines using the Delphi technique","volume":"54","author":"Wang","year":"2024","journal-title":"Intern. Med. J."},{"key":"B44","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1177\/0004867418758919","article-title":"More action needed: psychotropic prescribing in Australian residential aged care","volume":"53","author":"Westbury","year":"2018","journal-title":"Australian New Zealand J. Psychiatry"},{"key":"B45","unstructured":"ATC classification index with DDDs, 2025 Oslo, Norway: Norwegian Institute of Public Health\n          \n          \n          2024"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1345\/aph.1Q138","article-title":"Drug-related problems detected in Australian Community Pharmacies: the PROMISe trial","volume":"45","author":"Williams","year":"2011","journal-title":"Ann. Pharmacother."},{"key":"B47","doi-asserted-by":"publisher","first-page":"472","DOI":"10.5694\/mja2.52637","article-title":"2024 Royal Australian College of General Practitioners and healthy bones Australia guideline for osteoporosis management and fracture prevention in postmenopausal women and men over 50 years of age","volume":"222","author":"Wong","year":"2025","journal-title":"Med. J. Aust."},{"key":"B48","volume-title":"Medication safety in polypharmacy: technical report","year":""},{"key":"B49","volume-title":"International statistical classification of diseases and related health problems, 10th revision (ICD-10)","year":""}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1690600\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:41:30Z","timestamp":1761720090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1690600\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":49,"alternative-id":["10.3389\/fphar.2025.1690600"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1690600","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"article-number":"1690600"}}